Etarfion

Indication : Rheumatoid Arthritis
Etarfion® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active rheumatoid arthritis (RA).
Etarfion® can be initiated in combination with Methotrexate (MTX) or used alone.

Composition : Each vial Etarfion® contains Etanercept 25 mg, Mannitol, Sucrose , Tromethamine

Presentation : Etarfion® lyophilized powder for injection 25 mg Box, 1 vial @ 25 mg

On medical prescription only.